Mark Wirth

819 total citations
9 papers, 663 citations indexed

About

Mark Wirth is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, Mark Wirth has authored 9 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Pharmacology. Recurrent topics in Mark Wirth's work include Pharmacogenetics and Drug Metabolism (3 papers), Glioma Diagnosis and Treatment (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Mark Wirth is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Glioma Diagnosis and Treatment (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Mark Wirth collaborates with scholars based in United States, China and United Kingdom. Mark Wirth's co-authors include Kevin B. Alton, Stephen W.J. Wang, Ian Knemeyer, Jaime A. Yáñez, Paul Statkevich, Vijay Batra, Eric K. Rowinsky, Sharyn D. Baker, Margaret Dugan and David L. Cutler and has published in prestigious journals such as Advanced Drug Delivery Reviews, European Journal of Pharmacology and Toxicology and Applied Pharmacology.

In The Last Decade

Mark Wirth

9 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Wirth United States	9	190	138	128	125	124	9	663
Yuyang Zhang China	16	182 1.0×	170 1.2×	34 0.3×	144 1.2×	161 1.3×	50	701
How-Sung Lee Singapore	12	217 1.1×	73 0.5×	44 0.3×	36 0.3×	324 2.6×	17	823
Ju‐Hee Oh South Korea	18	369 1.9×	52 0.4×	60 0.5×	29 0.2×	175 1.4×	86	844
Feng Shao China	16	353 1.9×	64 0.5×	22 0.2×	94 0.8×	102 0.8×	51	756
Masaki Ishigai United States	16	254 1.3×	42 0.3×	81 0.6×	41 0.3×	128 1.0×	52	748
Arzu Onay-Beşi̇kçi̇ Türkiye	17	356 1.9×	31 0.2×	30 0.2×	110 0.9×	47 0.4×	37	941
Wenhao Xia China	14	237 1.2×	42 0.3×	20 0.2×	77 0.6×	40 0.3×	29	670
Marianna Zolotovskaia Russia	11	324 1.7×	109 0.8×	44 0.3×	15 0.1×	100 0.8×	27	741
Yaxin Lu China	16	273 1.4×	77 0.6×	19 0.1×	43 0.3×	59 0.5×	48	712

Countries citing papers authored by Mark Wirth

Since Specialization

Citations

This map shows the geographic impact of Mark Wirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wirth more than expected).

Fields of papers citing papers by Mark Wirth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Wirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wirth. The network helps show where Mark Wirth may publish in the future.

Co-authorship network of co-authors of Mark Wirth

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Wirth. A scholar is included among the top collaborators of Mark Wirth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Wirth. Mark Wirth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Hawes, Brian E., Ying Zhai, David Hesk, et al.. (2015). In vitro pharmacological characterization of vorapaxar, a novel platelet thrombin receptor antagonist. European Journal of Pharmacology. 762. 221–228. 14 indexed citations

Chowdhury, Swapan K., et al.. (2011). Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: Investigation of nicotinic acid receptor agonists. Toxicology and Applied Pharmacology. 255(1). 48–56. 43 indexed citations

Yáñez, Jaime A., Stephen W.J. Wang, Ian Knemeyer, Mark Wirth, & Kevin B. Alton. (2011). Intestinal lymphatic transport for drug delivery. Advanced Drug Delivery Reviews. 63(10-11). 923–942. 208 indexed citations

Ramanathan, Ragu, Larisa Reyderman, Kenneth Kulmatycki, et al.. (2007). Disposition of loratadine in healthy volunteers. Xenobiotica. 37(7). 753–769. 28 indexed citations

Ramanathan, Ragu, Larisa Reyderman, S. K. Chowdhury, et al.. (2007). Disposition of desloratadine in healthy volunteers. Xenobiotica. 37(7). 770–787. 22 indexed citations

Reyderman, Larisa, Paul Statkevich, C. Mohan Thonoor, et al.. (2004). Disposition and pharmacokinetics of temozolomide in rat. Xenobiotica. 34(5). 487–500. 50 indexed citations

Affrime, Melton B., Francis M. Cuss, Desmond Padhi, et al.. (2000). Bioavailability and Metabolism of Mometasone Furoate following Administration by Metered‐Dose and Dry‐Powder Inhalers in Healthy Human Volunteers. The Journal of Clinical Pharmacology. 40(11). 1227–1236. 79 indexed citations

Baker, Sharyn D., Mark Wirth, Paul Statkevich, et al.. (1999). Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer.. PubMed. 5(2). 309–17. 194 indexed citations

Chowdhury, Swapan K., et al.. (1999). An LC/MS/MS method for the quantitation of MTIC (5-(3-N-methyltriazen-1-yl)-imidazole-4-carboxamide), a bioconversion product of temozolomide, in rat and dog plasma. Journal of Pharmaceutical and Biomedical Analysis. 19(5). 659–668. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact